Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort study.
Trab T, Baech J, Jakobsen LH, Husby S, Severinsen MT, Eloranta S, Gørløv JS, Jørgensen JM, Gudbrandsdottir S, Larsen TS, Brown P, Grønbæk K, Smedby KE, El-Galaly TC. Trab T, et al. Among authors: brown p. Lancet Haematol. 2023 Oct;10(10):e838-e848. doi: 10.1016/S2352-3026(23)00212-0. Epub 2023 Sep 6. Lancet Haematol. 2023. PMID: 37689081
BEAM+autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre. Efficacy, toxicity and engraftment in relation to stem-cell source and previous treatment.
Geisler CH, Hansen MM, Andersen NS, Brown P, Christensen LD, Dickmeiss E, Ersbøll J, Myhre J, Hansen M, Juhl BR, Mortensen BT, Pedersen-Bjergaard J. Geisler CH, et al. Among authors: brown p. Eur J Haematol. 1998 Sep;61(3):173-82. doi: 10.1111/j.1600-0609.1998.tb01081.x. Eur J Haematol. 1998. PMID: 9753413
Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.
El-Galaly TC, Mylam KJ, Brown P, Specht L, Christiansen I, Munksgaard L, Johnsen HE, Loft A, Bukh A, Iyer V, Nielsen AL, Hutchings M. El-Galaly TC, et al. Among authors: brown p. Haematologica. 2012 Jun;97(6):931-6. doi: 10.3324/haematol.2011.056010. Epub 2011 Dec 29. Haematologica. 2012. PMID: 22207683 Free PMC article.
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
Geisler CH, Kolstad A, Laurell A, Jerkeman M, Räty R, Andersen NS, Pedersen LB, Eriksson M, Nordström M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E; Nordic Lymphoma Group. Geisler CH, et al. Among authors: brown p. Br J Haematol. 2012 Aug;158(3):355-62. doi: 10.1111/j.1365-2141.2012.09174.x. Epub 2012 May 29. Br J Haematol. 2012. PMID: 22640180 Free article. Clinical Trial.
Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.
Asmar F, Punj V, Christensen J, Pedersen MT, Pedersen A, Nielsen AB, Hother C, Ralfkiaer U, Brown P, Ralfkiaer E, Helin K, Grønbæk K. Asmar F, et al. Among authors: brown p. Haematologica. 2013 Dec;98(12):1912-20. doi: 10.3324/haematol.2013.088740. Epub 2013 Jul 5. Haematologica. 2013. PMID: 23831920 Free PMC article. Clinical Trial.
Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma.
Mylam KJ, El-Galaly TC, Hutchings M, Brown P, Himmelstrup B, Gerke O, Gillstrøm D, Sillesen IB, Munksgaard L, Pedersen BB, Christiansen I, Jensen P, Nielsen AL, Pedersen LM. Mylam KJ, et al. Among authors: brown p. Leuk Lymphoma. 2014 Jul;55(7):1563-9. doi: 10.3109/10428194.2013.850165. Epub 2013 Nov 14. Leuk Lymphoma. 2014. PMID: 24144339
Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
El-Galaly TC, Mylam KJ, Bøgsted M, Brown P, Rossing M, Gang AO, Haglund A, Arboe B, Clausen MR, Jensen P, Pedersen M, Bukh A, Jensen BA, Poulsen CB, d'Amore F, Hutchings M. El-Galaly TC, et al. Among authors: brown p. Am J Hematol. 2014 Jun;89(6):575-80. doi: 10.1002/ajh.23688. Epub 2014 Feb 24. Am J Hematol. 2014. PMID: 24493389 Free article.
miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
Husby S, Ralfkiaer U, Garde C, Zandi R, Ek S, Kolstad A, Jerkeman M, Laurell A, Räty R, Pedersen LB, Pedersen A, Ehinger M, Sundström C, Karjalainen-Lindsberg ML, Delabie J, Clasen-Linde E, Brown P, Cowland JB, Workman CT, Geisler CH, Grønbæk K. Husby S, et al. Among authors: brown p. Blood. 2015 Apr 23;125(17):2669-77. doi: 10.1182/blood-2014-06-584193. Epub 2015 Mar 3. Blood. 2015. PMID: 25736311 Free article. Clinical Trial.
TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
Munch-Petersen HD, Asmar F, Dimopoulos K, Areškevičiūtė A, Brown P, Girkov MS, Pedersen A, Sjö LD, Heegaard S, Broholm H, Kristensen LS, Ralfkiaer E, Grønbæk K. Munch-Petersen HD, et al. Among authors: brown p. Acta Neuropathol Commun. 2016 Apr 22;4:40. doi: 10.1186/s40478-016-0307-6. Acta Neuropathol Commun. 2016. PMID: 27101868 Free PMC article.
6,917 results